Nirland Limited 13D and 13G filings for Conduit Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-01-21 5:00 pm Purchase | 2025-01-13 | 13G | Conduit Pharmaceuticals Inc. CDT | Nirland Limited | 153,500 9.979% | 133,500 (+667.50%) | Filing |
| 2024-10-18 4:15 pm Sale | 2024-10-11 | 13G | Conduit Pharmaceuticals Inc. CDT | Nirland Limited | 20,000 2.000% | -60,920 (-75.28%) | Filing |
| 2024-10-07 7:36 pm Sale | 2024-10-04 | 13G | Conduit Pharmaceuticals Inc. CDT | Nirland Limited | 80,920 8.300% | -64,080 (-44.19%) | Filing |
| 2024-08-13 4:29 pm Purchase | 2024-08-06 | 13G | Conduit Pharmaceuticals Inc. CDT | Nirland Limited | 145,000 14.800% | 79,797 (+122.38%) | Filing |
| 2023-10-02 4:30 pm Purchase | 2023-09-22 | 13G | Conduit Pharmaceuticals Inc. CDT | Nirland Limited | 65,203 8.800% | 65,203 (New Position) | Filing |